StockNews.AI
ADMA
StockNews.AI
168 days

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of Controls

1. ADMA Biologics is under investigation for potential securities law violations. 2. Shares dropped over 8% due to a delay in filing Form 10-K. 3. The audit by KPMG is focusing on evaluating internal controls. 4. Block & Leviton is aiding investors attempting to recover losses. 5. Whistleblowers may receive rewards for providing information to the SEC.

4m saved
Insight
Article

FAQ

Why Bearish?

The investigation and share drop signal investor concern and potential legal troubles, like prior instances with biotech firms suffering significant stock declines amid similar scrutiny.

How important is it?

The article highlights serious legal concerns that can deter investor confidence, impacting ADMA's stock value.

Why Short Term?

Immediate reactions due to the investigation and audit, with potential for rapid stock rebounds if issues are resolved; however, legal outcomes can linger.

Related Companies

KPMG
BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating ADMA Biologics, Inc. (Nasdaq: ADMA) for potential securities law violations. Investors who have lost money in their ADMA Biologics, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/adma.  What is this all about? Shares of ADMA Biologics are down over 8% in intraday trading on March 4, 2025, after the company announced a delay in filing its Form 10-K, citing an ongoing audit by KPMG focused on evaluating internal controls. Who is eligible? Anyone who purchased ADMA Biologics, Inc. common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more. What is Block & Leviton doing? Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money. What should you do next? If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at shareholders@blockleviton.com, or by phone at (888) 256-2510. Whistleblower? If you have non-public information about ADMA Biologics, Inc., you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at shareholders@blockleviton.com or by phone at (888) 256-2510. Why should you contact Block & Leviton? Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website www.blockleviton.com, call (888) 256-2510 or email shareholders@blockleviton.com with any questions. This notice may constitute attorney advertising. CONTACT:BLOCK & LEVITON LLP260 Franklin St., Suite 1860Boston, MA 02110Phone: (888) 256-2510Email: shareholders@blockleviton.com 

Related News